SCP
WST icon

Syntal Capital Partners’s West Pharmaceutical WST Stock Holding History

Syntal Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,977
Closed -$1.64M – 131
2020
Q3 		$1.64M Buy
5,977
+19
+0.3% +$5.03K 0.74% 26
2020
Q2 		$1.35M Buy
+5,958
New +$1.17M 0.64% 47

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Syntal Capital Partners's WST Position: Q4 2020 in Review

Syntal Capital Partners sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 5,977 shares — an estimated $1.64M sold.

Syntal Capital Partners first reported a position in WST in Q2 2020 and held it in 2 quarters. The position peaked at $1.64M in Q3 2020. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

  • Syntal Capital Partners reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Syntal Capital Partners sold 5,977 West Pharmaceutical shares in Q4 2020, an estimated $1.64M.
  • Syntal Capital Partners first reported a position in West Pharmaceutical in Q2 2020 and held it in 2 quarters.
  • Syntal Capital Partners's West Pharmaceutical position peaked at $1.64M in Q3 2020.
  • 592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Syntal Capital Partners's 13F filing for Q4 2020, filed 11 Feb 2021.